JCM | Free Full-Text | Pediatric Acute Myeloid Leukemia—Past, Present, and Future Next
Article in Journal Sexual Habits and Sexual Dysfunctions in a Sample of Patients with Psychotic …

MicroRNAs (miRNAs) are non-coding single-stranded RNA molecules encoded by
endogenous genes with a length of about 22 nucleotides. The dysregulation of miRNAs has …

Despite the maximum intensification of chemotherapy and the increased use of
hematopoietic stem cell transplantation (HCT) in pediatric patients with acute myeloid …

Abstract Pediatric Acute Myeloid Leukemia (AML) is a rare and heterogeneous disease
characterized by a high prevalence of gene fusions as driver mutations. Despite the …

Background This is the first national study on trends in cancer survival and mortality for
children and young adolescents in the Netherlands including unique information on stage at …

Acute myeloid leukemia (AML) is a very heterogeneous hematological malignancy that
accounts for approximately 20% of all pediatric leukemia cases. The outcome of pediatric …

Simple Summary Research on leukemia has often led to novel approaches in clinical
practice. Cytogenetical and molecular markers have been introduced in treatment protocols …

Acute myeloid leukemia (AML) is a heterogeneous disease with a genetic, epigenetic, and
transcriptional etiology mainly presenting somatic and germline abnormalities. AML …

Acute myeloid leukemia (AML) accounts for approximately 15–20% of all childhood
leukemia cases. The overall survival of children with acute myeloid leukemia does not …

Background. Acute myeloid leukemia (AML) is one of the most common hematological
malignancies and accounts for about 20% of childhood leukemias. Currently …